Cargando…
Cancer incidence in immunocompromised patients: a single-center cohort study
BACKGROUND: Diminished immune defense plays an important role in cancer development. Cancer risk in immunocompromised patients may differ. Identifying individuals with elevated cancer risk can inform strategies for routine cancer screening. This study aimed to understand and compare cancer incidence...
Autores principales: | Ilham, Sabrina, Willis, Connor, Kim, Kibum, Chung, Karen C., Wood, Brenda M., Tan, Malinda S., Tan, Chia Jie, Nguyen, Danielle T., Brixner, Diana I., Stenehjem, David D. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9830873/ https://www.ncbi.nlm.nih.gov/pubmed/36624408 http://dx.doi.org/10.1186/s12885-022-10497-4 |
Ejemplares similares
-
Tumor mutational burden in lung cancer: a systematic literature review
por: Willis, Connor, et al.
Publicado: (2019) -
Clinical Utility of Pharmacogenetic Testing and a Clinical Decision Support Tool to Enhance the Identification of Drug Therapy Problems Through Medication Therapy Management in Polypharmacy Patients
por: Kim, Kibum, et al.
Publicado: (2018) -
Positive Association between Peri-Surgical Opioid Exposure and Post-Discharge Opioid-Related Outcomes
por: Kim, Kibum, et al.
Publicado: (2022) -
Elevated incidence of alveolar echinococcosis in immunocompromised patients
por: Lachenmayer, A., et al.
Publicado: (2019) -
Application of Decision-Analytic Models in Personalized Medicine for CML Treatment Decisions Made by Payers, Providers, and Patients
por: Saverno, Kim R., et al.
Publicado: (2012)